Fusion VC’s Post

Witness firsthand the conversation between Jonathan Arambila, InnovoTEX's CEO and Merom Klein of Courage Growth Partners, on the role of the Keiretsu Due Diligence report in extracting maximum value from investors. It serves as a key marketing tool in attracting funding for vital ovarian cancer research. Explore how in-depth due diligence is crafting paths to success for innovators and investors alike. Be a guest at our next meeting. Drop a line in the comments and we will send you a Zoom link. #DueDiligenceAdvantage #InnovativeFunding #angelinvesting

Witness firsthand the conversation between Jonathan Arambila, InnovoTEX's CEO and Merom Klein of Courage Growth Partners, on the role of the Keiretsu Due Diligence report in extracting maximum value from investors. It serves as a key marketing tool in attracting funding for vital ovarian cancer research. Explore how in-depth due diligence is crafting paths to success for innovators and investors alike. Be a guest at our next meeting. Drop a line in the comments and we will send you a Zoom link. #DueDiligenceAdvantage #InnovativeFunding #angelinvesting

Witness firsthand the conversation between Jonathan Arambila, InnovoTEX's CEO and Merom Klein of Courage Growth Partners, on the role of the Keiretsu Due Diligence report in extracting maximum value from investors. It serves as a key marketing tool in attracting funding for vital ovarian cancer research. Explore how in-depth due diligence is crafting paths to success for innovators and investors alike. Be a guest at our next meeting. Drop a line in the comments and we will send you a Zoom link. #DueDiligenceAdvantage #InnovativeFunding #angelinvesting

Can AI transform cancer diagnostics and treatment on a global scale? In Episode Two of Startup Insider, a new series from Startup Daily and Dell Technologies, the founders of NanoCube Health – Lisa Milani and Dr Shawn Goussous – test the limits of what’s possible and attract interest from abroad. Watch the four-part series here: https://lnkd.in/ga2MJSAc

On The Rate of Change Podcast hosted by Murdoch Gatti, VentureCrowd CEO Steven Maarbani shared an inspiring story about our portfolio company, EnGeneIC. Here’s the journey: 💡 Two ex-CSIRO scientists created a cutting-edge cancer treatment with nanocell technology. 💰 VentureCrowd raised $5M, helping EnGeneIC scale and secure key Southeast Asia partnerships. 🌍 Today, a late-stage pancreatic cancer patient, given two months to live, is now alive, two years later and tumor-free—an unprecedented achievement. This is the power of digital investment driving innovation that changes lives. ✨ Now, EnGeneIC is back on VentureCrowd, raising to scale Phase IIA trials, expand manufacturing, and drive global commercialisation. 📢 Join their journey to be a part of this growth—register your interest today! 👉 https://bit.ly/3YQuqZ6 #VentureCrowd #EnGeneIC Always consider the offer documents before investing. Past performance is not a reliable indicator of future performance.

Over 50,000 attendees, more than 200 sessions, and nearly 30,000 social mentions - ASCO 2024 was buzzing! 🐝 Our team sifted through all the digital noise to bring you the top trends, hottest topics, and key takeaways. Dive into our social listening report to see what mattered most at this year's conference. Get the insights: https://lnkd.in/e4yi8_8Y #ASCO2024 #oncology #lifescience #insights

Hello everyone I would like to share that we have received participation certificate in International Conference On emerging Trends in Computational Science And Engineering. It was a great experience participating in the conference. We had presented the paper on the Breast cancer prediction using Data Analytics. This was a team effort and contributions of each of the team members was remarkable. #computerscience #breastcancersupport #dataanalysts #conference #paperpresentation #realtimeanalytics #teamachievement #team #engineeringstudent

A Massachusetts-based start-up uses biochemical reactions to visualize cancer and improve lumpectomies. Howard Hechler, CEO of Lumicell, recognizes the constraints of current techniques and presents the start-up’s solution LumiSystem, a combination of the imaging agent LUMISIGHT and Lumicell Direct Visualization System (DVS), as a way to detect #cancer that otherwise would go undetected. Here's how Lumicell is shedding light on residual cancer: https://bit.ly/4fI4fuU #medtech #medicaldevices #startups  

This is an outstanding use of technology! #Iwork4dell In this clip, we dive into how Dell Technologies and Weka are revolutionizing cancer research with Memorial Sloan Kettering using the power of their supercomputer, Iris. 🔍 With Iris's robust infrastructure, researchers have reduced wall clock time by an astonishing 30X, propelling us closer to groundbreaking discoveries in cancer research! ✨ Together, we are making a difference! Watch the full video here: https://dell.to/3OAD9K8 #iwork4dell

Transforming cancer diagnosis is no longer a dream! Meet Primaa, an innovative French startup leveraging AI to make accurate cancer diagnoses accessible 🚀 Since their debut at #VivaTech, we’ve watched them forge meaningful connections and refine their groundbreaking solutions, showcasing their tech to key industry leaders and decision makeres. Did you catch them this year at VivaTech? 👀 Dive into this #VivaStory with Co-founder Fanny SOCKEEL MASSART to learn how Primaa is changing the game in healthcare! 💡